|
3M1I
Crystal structure of yeast CRM1 (Xpo1p) in complex with yeast RanBP1 (Yrb1p) and yeast RanGTP (Gsp1pGTP)
Deposited 2010-03-05
|
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1084(1084 aa)
|
Mutation:A deletion mutant (residues 377-413 deleted)
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;293 K;0.1M Bis-Tris, 0.2M ammonium nitrate, 18% PEG3350, pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.00 Å
R-free 0.220
|
|
3VYC
Crystal structure of unliganded Saccharomyces cerevisiae CRM1 (Xpo1p)
Deposited 2012-09-22
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–1084(1084 aa)
|
Mutation:a deletion mutant in which residues 377-413 and 971-984 are deleted
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.6;293 K;0.2M KF, 16% PEG3350, pH 7.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.217
|
|
3WYG
Crystal structure of Xpo1p-PKI-Gsp1p-GTP complex
Deposited 2014-08-26
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1084(1084 aa)
|
Not recorded
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.7;0.1M TRIS, 15% PEG20000, PH 7.7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
|
Resolution 2.15 Å
R-free 0.220
|
|
4GMX
Crystal structure of KPT185 in complex with CRM1-Ran-RanBP1
Deposited 2012-08-16
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
Fragment:UNP residues 1-1058
|
Mutation:T539C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 2
K85 propan-2-yl 3-{3-[3-methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}propanoate × 1
GOL GLYCEROL × 6
CL CHLORIDE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.197
|
|
4GPT
Crystal structure of KPT251 in complex with CRM1-Ran-RanBP1
Deposited 2012-08-21
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
Fragment:UNP residues 1-1058
|
Mutation:T539C,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 2
CL CHLORIDE ION × 5
51K 2-(2-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}ethyl)-1,3,4-oxadiazole × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.22 Å
R-free 0.210
|
|
4HAT
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539C,Y1022C
Mutation:T539C,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 3
LMB Leptomycin B, bound form × 1
GOL GLYCEROL × 2
CL CHLORIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.78 Å
R-free 0.173
|
|
4HAU
Crystal structure of CRM1 inhibitor Ratjadone A in complex with CRM1-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539C,Y1022C
Mutation:T539C,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 4
RJA Ratjadone A, bound form × 1
GOL GLYCEROL × 3
CL CHLORIDE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.00 Å
R-free 0.207
|
|
4HAV
Crystal structure of CRM1 inhibitor Anguinomycin A in complex with CRM1-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539C,Y1022C
Mutation:T539C,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 4
AA8 Anguinomycin A, bound form × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.00 Å
R-free 0.220
|
|
4HAW
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(K548A)-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539C,K548A,Y1022C
Mutation:T539C,K548A,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 2
GOL GLYCEROL × 3
EDO 1,2-ETHANEDIOL × 2
LMB Leptomycin B, bound form × 1
CL CHLORIDE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.90 Å
R-free 0.209
|
|
4HAX
Crystal structure of CRM1 inhibitor Ratjadone A in complex with CRM1(K579A)-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539C,K579A,Y1022C
Mutation:T539C,K579A,Y1022C
|
RJA Ratjadone A, bound form × 1
GOL GLYCEROL × 3
EDO 1,2-ETHANEDIOL × 3
CL CHLORIDE ION × 3
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.28 Å
R-free 0.216
|
|
4HAY
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(K548E,K579Q)-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539C,K548E,K579Q,Y1022C
Mutation:T539C,K548E,K579Q,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 5
LMB Leptomycin B, bound form × 1
CL CHLORIDE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.30 Å
R-free 0.230
|
|
4HAZ
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(R543S,K548E,K579Q)-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539C,R543S,K548E,K579Q,Y1022C
Mutation:T539C,R543S,K548E,K579Q,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 5
LBF Leptomycin B × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.90 Å
R-free 0.209
|
|
4HB0
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(K541Q,K542Q,R543S,K545Q,K548Q,K579Q)-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539C,K541Q,K542Q,R543S,K545Q,K548Q,K579Q,Y1022C
Mutation:T539C,K541Q,K542Q,R543S,K545Q,K548Q,K579Q,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
LBF Leptomycin B × 1
CL CHLORIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.20 Å
R-free 0.225
|
|
4HB2
Crystal structure of CRM1-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539C,Y1022C
Mutation:T539C,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 4
EDO 1,2-ETHANEDIOL × 2
CL CHLORIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.80 Å
R-free 0.201
|
|
4HB3
Crystal structure of CRM1(T539S)-Ran-RanBP1 with weakly bound unmodeled Leptomycin B
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:T539S,Y1022C
Mutation:T539S,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.80 Å
R-free 0.276
|
|
4HB4
Crystal structure of CRM1 inhibitor Leptomycin B in complex with CRM1(537DLTVK541/GLCEQ)-Ran-RanBP1
Deposited 2012-09-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:SEE REMARK 999
Chain C
414–1058(645 aa)
Fragment:SEE REMARK 999
|
Mutation:537DLTVK541 to GLCEQ, Y1022C
Mutation:537DLTVK541 to GLCEQ, Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 2
LMB Leptomycin B, bound form × 1
GOL GLYCEROL × 1
CL CHLORIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200 mM ammonium nitrate, 100 mM Bis-Tris, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.05 Å
R-free 0.218
|
|
5DH9
Crystal Structure of PKI NES Flip Mutant Peptide in complex with CRM1-Ran-RanBP1
Deposited 2015-08-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:V441D,D536G,T539C,V540E,K541Q,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;298 K;17% PEG3350, 100mM Bis-Tris pH6.4, 200mM NH4NO3, 10mM Spermine HCl
|
Resolution 2.55 Å
R-free 0.226
|
|
5DHA
Crystal Structure of CPEB4 NES Reverse Mutant Peptide in complex with CRM1-Ran-RanBP1
Deposited 2015-08-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:V441D,D536G,T539C,V540E,K541Q,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;298 K;17% PEG3350, 100mM Bis-Tris, 10mM Spermine HCl
|
Resolution 2.95 Å
R-free 0.240
|
|
5DHF
Crystal Structure of hRio2 NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2015-08-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:V441D,D536G,T539C,V540E,K541Q,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 4
CL CHLORIDE ION × 2
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;298 K;17% PEG3350, 100mM Bis-Tris pH6.4, 200mM NH4NO3, 10mM Spermine HCl
|
Resolution 2.29 Å
R-free 0.218
|
|
5DI9
Crystal Structure of hRio2 NES Reverse Mutant Peptide in complex with CRM1-Ran-RanBP1
Deposited 2015-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:V441D,D536G,T539C,V540E,K541Q,Y1022C, delta 377-413
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 4
ZN ZINC ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;298 K;17% PEG3350, 100mM Bis-Tris pH6.4, 200mM NH4NO3, 10mM Spermine HCl
|
Resolution 2.28 Å
R-free 0.211
|
|
5DIF
Crystal Structure of CPEB4 NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2015-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:V441D,D536G,T539C,V540E,K541Q,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 7
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;298 K;17% PEG3350, 100mM Bis-Tris pH6.4, 200mM NH4NO3, 10mM Spermine HCl
|
Resolution 2.09 Å
R-free 0.208
|
|
5JLJ
Crystal Structure of KPT8602 in complex with CRM1-Ran-RanBP1
Deposited 2016-04-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:T539C,Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 5
CL CHLORIDE ION × 1
6L8 (2R)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-2-(pyrimidin-5-yl)propanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;298 K;17% PEG3350, 100mM Bis-Tris pH6.6, 200mM Ammounium Nitrate
|
Resolution 2.50 Å
R-free 0.232
|
|
5UWH
Crystal Structure of Paxillin NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;16% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 20 mM HCl
|
Resolution 2.26 Å
R-free 0.218
|
|
5UWI
Crystal Structure of HDAC5 NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;17% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 10 mM spermine-HCl, 16 mM HCl
|
Resolution 2.14 Å
R-free 0.218
|
|
5UWJ
Crystal Structure of FMRP NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;17% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 10 mM spermine-HCl, 4 mM HCl
|
Resolution 2.22 Å
R-free 0.213
|
|
5UWO
Crystal Structure of Engineered FMRP-1b NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;16% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 12 mM HCl
|
Resolution 2.35 Å
R-free 0.223
|
|
5UWP
Crystal Structure of mDia2 NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;16% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 8 mM HCl
|
Resolution 2.05 Å
R-free 0.213
|
|
5UWQ
Crystal Structure of CDC7 NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;16% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 8 mM HCl
|
Resolution 2.28 Å
R-free 0.225
|
|
5UWR
Crystal Structure of CDC7 NES Peptide (extended) in complex with CRM1-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;17% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 10 mM spermine-HCl
|
Resolution 2.24 Å
R-free 0.222
|
|
5UWS
Crystal Structure of X11L2 NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;17% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 10 mM spermine-HCl
|
Resolution 2.40 Å
R-free 0.222
|
|
5UWT
Crystal Structure of Hxk2 Peptide in complex with CRM1 K579A mutant-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;17% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 20 mM HCl
|
Resolution 2.34 Å
R-free 0.227
|
|
5UWU
Crystal Structure of SMAD4 NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;16% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 16 mM HCl
|
Resolution 2.24 Å
R-free 0.211
|
|
5UWW
Crystal Structure of DEAF1 Peptide in complex with CRM1 K579A mutant-Ran-RanBP1
Deposited 2017-02-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;295 K;16% PEG3350, 100 mM Bis-Tris, pH 6.4, 200 mM ammonium nitrate, 16 mM HCl
|
Resolution 2.15 Å
R-free 0.226
|
|
5XOJ
Crystal structure of Xpo1p-PKI-Nup42p-Gsp1p-GTP complex
Deposited 2017-05-29
|
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
1–1084(1084 aa)
|
Mutation:residues 377-413 deleted
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.7;293 K;PEG20000, Tris-HCl
|
Resolution 2.20 Å
R-free 0.220
|
|
5YRO
RanL182A in complex with RanBP1-CRM1
Deposited 2017-11-09
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Mutation:D537G, T539C, V540E, K541Q
Mutation:D537G, T539C, V540E, K541Q
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 2
EDO 1,2-ETHANEDIOL × 1
GOL GLYCEROL × 1
CL CHLORIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG 3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH 6.6
|
Resolution 2.40 Å
R-free 0.245
|
|
5YST
RanM189D in complex with RanBP1-CRM1
Deposited 2017-11-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Fragment:lacking C-terminal inhibitory tail,lacking C-terminal inhibitory tail
Chain C
414–1052(639 aa)
Fragment:lacking C-terminal inhibitory tail,lacking C-terminal inhibitory tail
|
Mutation:D537G, T539C, V540E, K541Q
Mutation:D537G, T539C, V540E, K541Q
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 2
EDO 1,2-ETHANEDIOL × 1
CL CHLORIDE ION × 6
GOL GLYCEROL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG 3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH 6.6
|
Resolution 2.04 Å
R-free 0.238
|
|
5YSU
Plumbagin in complex with CRM1-RanM189D-RanBP1
Deposited 2017-11-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Mutation:D537G,T539C,V540E,K541Q,Y1022C
Mutation:D537G,T539C,V540E,K541Q,Y1022C
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 2
NO3 NITRATE ION × 4
F2X (2~{R})-2-methyl-5-oxidanyl-2,3-dihydronaphthalene-1,4-dione × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG 3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH 6.6
|
Resolution 2.30 Å
R-free 0.257
|
|
5YTB
RanY197A in complex with RanBP1-CRM1
Deposited 2017-11-17
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Chain C
414–1052(639 aa)
|
Mutation:D537G, T539C, V540E, K541Q, Y1022C
Mutation:D537G, T539C, V540E, K541Q, Y1022C
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
CL CHLORIDE ION × 7
GOL GLYCEROL × 3
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG 3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH 6.6
|
Resolution 2.30 Å
R-free 0.229
|
|
5ZPU
LFS829 in complex with CRM1-Ran-RanBP1
Deposited 2018-04-16
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Mutation:D537G, T539C, V540E, K541Q, Y1022C,D537G, T539C, V540E, K541Q, Y1022C
Mutation:D537G, T539C, V540E, K541Q, Y1022C,D537G, T539C, V540E, K541Q, Y1022C
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
D29 (Z)-{[(3E)-4-{(R)-[3,5-bis(trifluoromethyl)phenyl]sulfinyl}but-3-en-1-yl]imino}methanethiol × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH6.6
|
Resolution 2.60 Å
R-free 0.259
|
|
6A38
MVM NS2 NES in complex with CRM1-Ran-RanBP1
Deposited 2018-06-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
Fragment:lacking C-terminal inhibitory tail and H9 loop
|
Mutation:D537G, T539C, V540E, K541Q, Y1022C, 377-413 deletion, 441-461 deletion
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
GOL GLYCEROL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH6.6
|
Resolution 2.69 Å
R-free 0.256
|
|
6A3A
MVM NES mutant Nm2 in complex with CRM1-Ran-RanBP1
Deposited 2018-06-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
Fragment:lacking C-terminal inhibitory tail and H9 loop
|
Mutation:D537G, T539C, V540E, K541Q, Y1022C, 377-413 deletion, 441-461 deletion
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
GOL GLYCEROL × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH6.6
|
Resolution 2.30 Å
R-free 0.246
|
|
6A3B
MVM NES mutant Nm13 in complex with CRM1-Ran-RanBP1
Deposited 2018-06-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:D537G, T539C, V540E, K541Q, Y1022C, 377-413 deletion, 441-461 deletion
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
GOL GLYCEROL × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH6.6
|
Resolution 2.51 Å
R-free 0.254
|
|
6A3C
MVM NES mutant Nm12 in complex with CRM1-Ran-RanBP1
Deposited 2018-06-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
Fragment:lacking C-terminal inhibitory tail and H9 loop
|
Mutation:D537G, T539C, V540E, K541Q, Y1022C, 377-413 deletion, 441-461 deletion
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
GOL GLYCEROL × 2
CL CHLORIDE ION × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH6.6
|
Resolution 2.35 Å
R-free 0.266
|
|
6A3E
MVM NES mutant Nm15 in complex with CRM1-Ran-RanBP1
Deposited 2018-06-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:D537G, T539C, V540E, K541Q, Y1022C, 377-413 deletion, 441-461 deletion
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;18% PEG3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH6.6
|
Resolution 2.70 Å
R-free 0.241
|
|
6CIT
Crystal Structure of MVM NS2 NES Peptide in complex with CRM1-Ran-RanBP1
Deposited 2018-02-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–376(376 aa)
Chain C
414–1058(645 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 6
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;17% PEG3350, 100 MM Bis-Tris, pH 6.4, 200 mM ammonium nitrate
|
Resolution 2.03 Å
R-free 0.215
|
|
6LQ9
S109 in complex with CRM1-Ran-RanBP1
Deposited 2020-01-13
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
Fragment:lacking C-terminal inhibitory tail and H9 loop
|
Mutation:del 377-413, D537G, T539C, V540E, K541Q, Y1022C,
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
NO3 NITRATE ION × 5
CL CHLORIDE ION × 1
EQF (3~{R},4~{S})-1-[[6-chloranyl-5-(trifluoromethyl)pyridin-2-yl]amino]-3,4-dimethyl-pyrrolidine-2,5-dione × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;293 K;18% PEG3350, 200mM Ammonium Nitrate, 100mM Bis-Tris pH6.6
|
Resolution 2.50 Å
R-free 0.228
|
|
6M60
Plumbagin in complex with CRM1#-Ran-RanBP1
Deposited 2020-03-12
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:S27E , Q49E, del377-413, del441-461, D522K, D537G, T539C, V540E, K541Q, S553R, Q561E, A741T, Y1022C
|
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
NO3 NITRATE ION × 9
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
CL CHLORIDE ION × 3
DMS DIMETHYL SULFOXIDE × 3
F2X (2~{R})-2-methyl-5-oxidanyl-2,3-dihydronaphthalene-1,4-dione × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.12 M Monosaccharides (20 mM D-Glucose; 20 mM D-Mannose; 20 mM D-Galactose; 20 mM L-Fucose; 20 mM D-Xylose; 20 mM N-Acetyl-D-Glucosamine), 0.1 M buffer system 1 pH 6.5 (sodium HEPES and MOPS), and 50 % Precipitant Mix 2 (40% v/v Ethylene glycol; 20 % w/v PEG 8000)
|
Resolution 2.17 Å
R-free 0.213
|
|
6M6X
Oridonin in complex with CRM1#-Ran-RanBP1
Deposited 2020-03-16
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:S27E , Q49E, del377-413, del441-461, D522K, D537G, T539C, V540E, K541Q, S553R, Q561E, A741T, Y1022C
|
MG MAGNESIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
CL CHLORIDE ION × 4
ODN (1beta,6beta,7beta,8alpha,9beta,10alpha,13alpha,14R,16beta)-1,6,7,14-tetrahydroxy-7,20-epoxykauran-15-one × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.12 M Monosaccharides (20 mM D-Glucose; 20 mM D-Mannose; 20 mM D-Galactose; 20 mM L-Fucose; 20 mM D-Xylose; 20 mM N-Acetyl-D-Glucosamine), 0.1 M buffer system 1 pH 6.5 (sodium HEPES and MOPS), and 50 % Precipitant Mix 2 (40% v/v Ethylene glycol; 20 % w/v PEG 8000)
|
Resolution 2.88 Å
R-free 0.233
|
|
6X2M
Crystal Structure of unliganded CRM1-Ran-RanBP1
Deposited 2020-05-20
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:377-413 deleted
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.35 Å
R-free 0.261
|
|
6X2O
Crystal Structure of unliganded CRM1(E571K)-Ran-RanBP1
Deposited 2020-05-20
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:E582K
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;273 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.55 Å
R-free 0.254
|
|
6X2P
Crystal Structure of the Mek1NES peptide bound to CRM1
Deposited 2020-05-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;273 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.40 Å
R-free 0.252
|
|
6X2R
Crystal Structure of the 4E-TNES peptide bound to CRM1
Deposited 2020-05-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;273 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.30 Å
R-free 0.257
|
|
6X2S
Crystal Structure of Mek1(NQ)NES peptide bound to CRM
Deposited 2020-05-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;273 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.50 Å
R-free 0.246
|
|
6X2U
Crystal Structure of PKINES peptide bound to CRM1
Deposited 2020-05-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;273 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.20 Å
R-free 0.240
|
|
6X2V
Crystal Structure of PKI(DE)NES peptide bound to CRM1
Deposited 2020-05-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;273 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.82 Å
R-free 0.262
|
|
6X2W
Crystal Structure of PKINES peptide bound to CRM1(E571K)
Deposited 2020-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:E582K
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;273 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 3.00 Å
R-free 0.253
|
|
6X2X
Crystal Structure of Mek1NES peptide bound to CRM1(E571K)
Deposited 2020-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:E582K
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;273 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.46 Å
R-free 0.250
|
|
6X2Y
Crystal Structure of mDia2NES peptide bound to CRM1(E571K)
Deposited 2020-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Mutation:E582K
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;273 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.30 Å
R-free 0.256
|
|
6XJP
Crystal Structure of KPT-185 bound to CRM1 (537-DLTVK-541 to GLCEQ)
Deposited 2020-06-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:537-DLTVK-541 to GLCEQ
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
K85 propan-2-yl 3-{3-[3-methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}propanoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.80 Å
R-free 0.260
|
|
6XJR
Crystal Structure of KPT-185 bound to CRM1 (E582K, 537-DLTVK-541 to GLCEQ)
Deposited 2020-06-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:E582K, 537-DLTVK-541 to GLCEQ
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
K85 propan-2-yl 3-{3-[3-methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}propanoate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 1.94 Å
R-free 0.226
|
|
6XJS
Crystal Structure of KPT-330 bound to CRM1 (E582K, 537-DLTVK-541 to GLCEQ)
Deposited 2020-06-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:E582K, 537-DLTVK-541 to GLCEQ
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 2
V6A selinexor, bound form × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 1.94 Å
R-free 0.240
|
|
6XJT
Crystal Structure of KPT-8602 bound to CRM1 (537-DLTVK-541 to GLCEQ)
Deposited 2020-06-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:537-DLTVK-541 to GLCEQ
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
6L8 (2R)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-2-(pyrimidin-5-yl)propanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.41 Å
R-free 0.246
|
|
6XJU
Crystal Structure of KPT-8602 bound to CRM1 (E582K, 537-DLTVK-541 to GLCEQ)
Deposited 2020-06-24
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:E582K, 537-DLTVK-541 to GLCEQ
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
6L8 (2R)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-2-(pyrimidin-5-yl)propanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 2.19 Å
R-free 0.225
|
|
7L5E
Crystal Structure of KPT-330 bound to CRM1 (537-DLTVK-541 to GLCEQ)
Deposited 2020-12-21
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 1
V6A selinexor, bound form × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;17% (weight/vol) PEG3350, 100 mM Bis-Tris (pH 6.4), 200 mM ammonium nitrate, and 10 mM Spermine HCl
|
Resolution 1.94 Å
R-free 0.245
|
|
8QYZ
Crystal structure of hiNES2 in complex with Xpo1 and RanGTP
Deposited 2023-10-26
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1084(1084 aa)
|
Mutation:del(377-413)
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;Tris, PEG 20K, magnesium acetate
|
Resolution 3.00 Å
R-free 0.247
|
|
8QYZ
Crystal structure of hiNES2 in complex with Xpo1 and RanGTP
Deposited 2023-10-26
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–1084(1084 aa)
|
Mutation:del(377-413)
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;Tris, PEG 20K, magnesium acetate
|
Resolution 3.00 Å
R-free 0.247
|
|
8QYZ
Crystal structure of hiNES2 in complex with Xpo1 and RanGTP
Deposited 2023-10-26
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
1–1084(1084 aa)
|
Mutation:del(377-413)
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;Tris, PEG 20K, magnesium acetate
|
Resolution 3.00 Å
R-free 0.247
|
|
8QYZ
Crystal structure of hiNES2 in complex with Xpo1 and RanGTP
Deposited 2023-10-26
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain H
1–1084(1084 aa)
|
Mutation:del(377-413)
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;Tris, PEG 20K, magnesium acetate
|
Resolution 3.00 Å
R-free 0.247
|
|
9OGN
Crystal Structure of KPT396 in complex with CRM1-Ran-RanBP1
Deposited 2025-05-01
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:T539C, Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
CL CHLORIDE ION × 3
A1CBD 3-(3-{3-[(but-2-yn-1-yl)oxy]-5-(trifluoromethyl)phenyl}-1H-1,2,4-triazol-1-yl)-N-(piperidin-1-yl)propanamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;17% PEG3350, 100 mM Bis-Tris (pH 6.6) and 200 mM ammonium nitrate
|
Resolution 2.41 Å
R-free 0.224
|
|
9OGO
Crystal Structure of KPT185 in complex with CRM1(EH mutant)-Ran-RanBP1
Deposited 2025-05-01
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:V529E, T539C, F572H, Y1022C
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
K85 propan-2-yl 3-{3-[3-methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}propanoate × 1
CL CHLORIDE ION × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;298 K;17% PEG3350, 100 mM Bis-Tris (pH 6.6) and 200 mM ammonium nitrate
|
Resolution 2.37 Å
R-free 0.236
|
|
9VM1
MVM NS2 mutant Nm42 in complex with CRM1-Ran-RanBP1
Deposited 2025-06-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–1058(1058 aa)
|
Not recorded
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 1
NA SODIUM ION × 1
NO3 NITRATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;300 K;0.12 M Monosaccharides (20 mM D-Glucose; 20 mM D-Mannose; 20 mM D-Galactose; 20 mM L-Fucose; 20 mM D-Xylose; 20 mM N-Acetyl-D-Glucosamine), 0.1 M buffer system 1 pH 6.5 (sodium HEPES and MOPS), and 50 % Precipitant Mix 2 (40% v/v Ethylene glycol; 20 % w/v PEG 8000)
|
Resolution 2.45 Å
R-free 0.235
|
|
9X7O
Lansoprazole derivative in complex with CRM1-Ran-RanBP1
Deposited 2025-10-17
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–1058(1058 aa)
|
Mutation:S27E/Q49E/A51V/D537G/T539C/V540E/K541Q/S553R/Q561E/A741T/Y1022C
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
R-free 0.218
|